IRCT2015071722965N2
Completed
Phase 2
Evaluating the effects of oral N-acetyl cysteine as a Adjuvant therapy on controling clinical symtoms and serum level of inflammatory biomarkers including IL6,TNF-a, CRP and ESR in rhumatoid arthritis Patients
Vice chancellor for research, Hamadan University of Medical Sciences0 sites70 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Rheumatoid arthritis.
- Sponsor
- Vice chancellor for research, Hamadan University of Medical Sciences
- Enrollment
- 70
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with diagnosis of arthritis rhumatoid; Patients more than 18 years and less than 65 years; Patients with moderate to severe active disease
- •Exclusion criteria: Patients with active infection; Patients with mild active disease
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Evaluating the effects of oral N-acetyl cysteine as an adjuvant therapy for pain management and serum level of oxidative stress bio-markers in patients with painful diabetic neuropathyDiabetic polyneuropathy.Type 2 diabetes mellitus with diabetic polyneuropathyE11.42IRCT20150629022965N19Hamedan University of Medical Sciences140
Recruiting
Phase 3
evaluation of N-acetylcysteine on nitrosative stress in Rheumatoid arthritis patientsIRCT2017073022965N12Vice Chancellor for research of Hamadan University of Medical Sciences52
Completed
Phase 4
The effect of oral N-acetylcysteine on quantitative serum high sensitivity CRP and hemoglobin in hemodialysis patientsEnd stage renal disease.End stage kidney diseaseN 18.5IRCT2016111030821N1Vice Chancellor for research of Ardabil University of Medical Sciences40
Recruiting
Phase 3
Eeffect of oral administration of N- acetyl cysteine in Women with EndometriosisEndometriosis.Other endometriosisN80.8IRCT20100411003684N9Babol University of Medical Sciences60
Recruiting
Phase 2
Oral N-acetylcysteine (NAC) effectiveness in cystic fibrosis (CF)IRCT20090808002306N7Esfahan University of Medical Sciences45